Learn More
Medchemexpress LLC Poseltinib | 1353552-97-2 | 98.1% | 470.52 | 1 ML

Supplier: Medchemexpress LLC HY10901010MG
Poseltinib is an orally active, selective, irreversible small molecule Bruton tyrosine kinase (BTK) inhibitor with an IC50 of 1.95 nM. It effectively inhibits signaling mediated by B cell receptors (BCR), Fc receptors (FcR), and Toll-like receptors (TLR). Poseltinib also exhibits anti-inflammatory activity and is being researched for rheumatoid arthritis.
- Orally active, selective, irreversible small molecule Bruton tyrosine kinase (BTK) inhibitor.
- Effectively inhibits signaling mediated by B cell receptors (BCR), Fc receptors (FcR), and Toll-like receptors (TLR).
- Exhibits anti-inflammatory activity.
- Potential for research in rheumatoid arthritis.
- Appearance: solid, light yellow to yellow.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.